Evidence map›Paper›PMID 39560304›Full record

ArticleFuture science OA2024

Hyperhomocysteinemia prevalence among patients with venous thromboembolism.

R Ben Salah, M Boudaya, S Fendri, R Marrekchi, Z Bahloul, K Jamoussi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future science OA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

R Ben SalahDepartment of internal medicine, Faculty of Medicine, University of SFAX, Sfax, Tunisia.
M BoudayaBiochemistry Laboratory, Hedi Chaker University Hospital, Sfax, Tunisia.
S FendriBiochemistry Laboratory, Hedi Chaker University Hospital, Sfax, Tunisia.
R MarrekchiBiochemistry Laboratory, Hedi Chaker University Hospital, Sfax, Tunisia.
Z BahloulDepartment of internal medicine, Faculty of Medicine, University of SFAX, Sfax, Tunisia.
K JamoussiBiochemistry Laboratory, Hedi Chaker University Hospital, Sfax, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe objectives of this study were to determine the plasma homocysteine (Hcy) levels and the prevalence of Hyperhomocysteinemia

methodsit was an observational case-control study including patients hospitalized for the management of unprovoked DVT. For each subject, a routine biochemical assay was conducted, including plasma homocysteine measurement and determination of vitamin B12 and B9 levels, as these vitamins are essential for assessing hyperhomocysteinemia in DVT patients due to their role in regulating homocysteine.

resultsWe observed an increased mean plasma Hcy level compared to controls and the prevalence of Hyperhomocysteinemia 61.7% against 4% in the control subjects. The risk of developing DVT with HHC is 3.54.

conclusionOur study found that homocysteine levels were higher in patients with DVT than in controls.

Indexed as

deep vein thrombosishomocysteine levelsHyperhomocysteinemiaprevalence

Identifiers

PMID39560304
PMCPMC11581158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.